Scarica l'app Stockscreener
0.00
100.00%
-1.16
Dopo l'orario di chiusura:
1.15
1.15
+
Hookipa Pharma Inc Borsa (HOOK) Ultime notizie
HOOKIPA Pharma Inc (HOOK) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
HOOKIPA Pharma Inc (HOOK) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
HOOKIPA Pharma Inc (HOOK) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
HOOKIPA Pharma Inc (HOOK) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
HOOKIPA Pharma Inc (HOOK) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
HOOKIPA Pharma Inc (HOOK) Institutional Confidence - TradingKey
HOOKIPA Pharma Inc (HOOK) Valuation: PE, PB & Fair Value Analysis - TradingKey
HOOKIPA Pharma Inc (HOOK) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
HOOKIPA Pharma Inc (HOOK) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
HOOKIPA Pharma Inc stock (US43906K1007): Immuno-oncology small cap after recent funding and pipeline - AD HOC NEWS
HOOKIPA Pharma stock (US43906K1007): cash runway update and pipeline focus after latest quarterly re - AD HOC NEWS
HOOKIPA Pharma stock (US43906K1007): pipeline update keeps immunotherapy story in focus - AD HOC NEWS
HOOKIPA Pharma Inc.Common Stock (Nasdaq:HOOK) Stock Quote - The Chronicle-Journal
HOOKIPA Pharma Inc stock (US43906K1007): Delisted to OTC amid price volatility - AD HOC NEWS
TradingKey - TradingKey
HOOKIPA Pharma Inc stock (US43906K1007): Biotech focuses on infectious disease and oncology pipeline - AD HOC NEWS
HOOKIPA Pharma Inc stock (US43906K1007): Is its viral vector platform strong enough to unlock biotec - AD HOC NEWS
Can HOOKIPA Pharma Inc reach all time highs this yearQuarterly Portfolio Review & Safe Swing Trade Setup Alerts - baoquankhu1.vn
Earnings Report: Can HOOKIPA Pharma Inc reach all time highs this year - baoquankhu1.vn
New Highs: How does HOOKIPA Pharma Inc compare to its peersQuarterly Risk Review & Community Trade Idea Sharing Platform - baoquankhu1.vn
Winners Losers: Is HOOKIPA Pharma Inc stock a smart retirement pick2026 Support & Resistance & Safe Capital Allocation Plans - baoquankhu1.vn
HOOKIPA Pharma Inc Stock: Areola Virus Vaccine Innovator Seeks Prophylactic Breakthrough with ISIN U - AD HOC NEWS
HOOKIPA Pharma Announces Completion of Sale of Oncology Assets to NeoTrail Therapeutics - markets.businessinsider.com
NeoTrail Therapeutics, Inc. completed the acquisition of Oncology Assets from HOOKIPA Pharma Inc. (OTCPK : HOOK). - MarketScreener
Breakout Move: How does HOOKIPA Pharma Inc compare to its peers2026 Sector Review & Real-Time Volume Triggers - baoquankhu1.vn
New Highs: Will HOOKIPA Pharma Inc benefit from government policy2026 Historical Comparison & High Return Stock Watch Alerts - baoquankhu1.vn
HOOKIPA Pharma Inc stock faces renewed scrutiny after failed merger and pipeline updates in biotech - AD HOC NEWS
Aug Rallies: Can HOOKIPA Pharma Inc reach all time highs this yearStop Loss & Reliable Trade Execution Plans - baoquankhu1.vn
Gilead (GILD) to Acquire HOOK for $10 million - msn.com
HOOKIPA Pharma Stock: What Latest Pipeline Moves Mean for U.S. Investors - AD HOC NEWS
HOOKIPA Pharma (HOOK) Expected to Announce Earnings on Friday - Defense World
Risk Check: Will HOOKIPA Pharma Inc benefit from government policy2025 EndofYear Setup & Entry Point Confirmation Signals - baoquankhu1.vn
Why HOOKIPA Pharma Inc. stock remains on buy lists2025 Growth vs Value & AI Powered Market Entry Ideas - mfd.ru
How does HOOKIPA Pharma Inc. compare to its peersWeekly Trade Summary & Real-Time Stock Price Movement Reports - mfd.ru
Aug Outlook: What is the dividend yield of HOOKIPA Pharma Inc2025 Risk Factors & AI Forecasted Entry/Exit Points - baoquankhu1.vn
Published on: 2026-02-12 12:26:37 - mfd.ru
Why retail investors pile into HOOKIPA Pharma Inc. stockIPO Watch & Capital Efficiency Focused Strategies - mfd.ru
HOOKIPA Pharma T0 Sell Oncology Assets HB-200 And HB-700 To NeoTrail Therapeutics - Nasdaq
HOOKIPA Pharma (HOOK) Divests Key Immuno-Oncology Assets - GuruFocus
HOOKIPA Pharma Announces Sale of Oncology Assets to NeoTrail Therapeutics - markets.businessinsider.com
HOOKIPA Pharma Sells Oncology Assets To NeoTrail Therapeutics - citybiz
HOOKIPA Pharma Inc. Sells Immuno-Oncology Assets HB-200 and HB-700 to NeoTrail Therapeutics - Quiver Quantitative
Hookipa Pharma Announces Sale Of Oncology Assets To Neotrail Therapeutics - TradingView
Dip Buying: How does HOOKIPA Pharma Inc compare to its peersWeekly Earnings Recap & Growth Oriented Trading Recommendations - baoquankhu1.vn
Stock Analysis: Can HOOKIPA Pharma Inc deliver consistent EPS growthJuly 2025 Analyst Calls & Capital Efficiency Focused Ideas - baoquankhu1.vn
Growth Value: Will HOOKIPA Pharma Inc benefit from government policyTrade Volume Summary & Daily Oversold Bounce Ideas - baoquankhu1.vn
Will HOOKIPA Pharma Inc. stock benefit from commodity pricesMarket Performance Summary & Free Accurate Trade Setup Notifications - ulpravda.ru
Will HOOKIPA Pharma Inc. stock outperform growth indexesQuarterly Risk Review & High Conviction Buy Zone Alerts - Улправда
How risky is HOOKIPA Pharma Inc. stock nowQuarterly Profit Report & Long-Term Growth Portfolio Plans - Улправда
Why HOOKIPA Pharma Inc. stock remains resilientTrade Entry Report & AI Optimized Trade Strategies - Улправда
Is CEL SCI Corporation stock a contrarian buyPortfolio Performance Summary & Risk Adjusted Buy and Sell Alerts - ulpravda.ru
Update Report: Will HOOKIPA Pharma Inc. stock outperform growth indexes2025 Momentum Check & Fast Momentum Entry Tips - Улправда
Will HOOKIPA Pharma Inc. stock maintain momentum in 2025Weekly Loss Report & Fast Momentum Stock Entry Tips - Улправда
Is HOOKIPA Pharma Inc. stock near bottom after declineJuly 2025 Rallies & Weekly Market Pulse Alerts - Улправда
Aug Sentiment: Why HOOKIPA Pharma Inc stock remains resilientJuly 2025 PostEarnings & Growth Focused Stock Reports - moha.gov.vn
HOOKIPA Pharma Inc. Completes Asset Sale of HB-400 and HB-500 Programs to Gilead Sciences - Quiver Quantitative
0.74%
1.44%
Capitalizzazione:
|
Volume (24 ore):